Introduction

!
Hypoxia acts as an initial regulator of the angiogenic switch. It stimulates the restoration of oxygen homeostasis through angiogenesis activation. Angiogenesis is critical for normal physiological and pathological processes, including cancer development [1] . Most solid tumors cannot grow beyond a certain size until they establish a blood supply by inducing the formation of new vessels sprouting [2] . Antiangiogenesis is becoming an important strategy for cancer therapy. The proangiogenic growth factors are overexpressed in cancer cells in response to hypoxia. HIF is a transcription factor that consists of α-β-heterodimers, including HIF-1α, HIF-2α, and HIF-β. Either HIF-1α or HIF-2α can heterodimerize with HIF-β to form the HIF transcription factor. It binds with hypoxia response elements and promotes an angiogenesis-related mRNA transcription of VEGF [3] . VEGF regulates the function of endothelial cells and stimulates tumor vascularization. mTOR regulates diverse physiological functions of cancer cells, including proliferation, apoptosis, and metabolism [4] . Activated mTOR phosphorylates its downstream target S6K1 and the eIF-4E binding protein 1, and subsequently promotes mRNA transcription and protein translation. Previous studies demonstrated that mTOR mediates the expression of HIF-1α and VEGF [5] . In mTORhyperactivated vascular endothelial cells, HIF-1α expression and VEGF production are increased [6] . mTOR inhibitors, including rapamycin and its
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The mammalian target of rapamycin is critical in hypoxia-triggered angiogenesis. Cardamonin inhibits proliferation of various cancer cells through suppressing the mammalian target of rapamycin. In this study, the antiangiogenic effect of cardamonin on CoCl 2 -mimicked hypoxic SKOV3 cells was investigated. Cardamonin exhibited an antiproliferative effect on normal and CoCl 2 -mimicked hypoxic SKOV3 cells. Messenger RNA expression of vascular endothelial growth factor was inhibited with cardamonin and rapamycin in SKOV3 cells under both conditions. However, cardamonin had little effect on the messenger RNA expression of hypoxia-inducible factor-α. Cardamonin inhibited the protein expression of hypoxia-inducible factor-1α, hypoxia inducible factor-2α, vascular endothelial growth factor, and the phosphorylation of mammalian target of rapamycin and ribosomal S6 kinase 1. Furthermore, angiogenesis induced by a medium of SKOV3 cells was reduced by cardamonin in a chicken embryo allantois membrane model. These findings suggest that cardamonin inhibits protein expression of hypoxia-inducible factor-α, and vascular endothelial growth factor, which was induced by CoCl 2 -mimicked hypoxia and this effect partially correlates with the mammalian target of rapamycin inhibition. Cardamonin might be a potential angiogenesis inhibitor for ovarian cancer therapy.
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proline hydroxylase 2 S6K1: ribosomal S6 kinase 1 VEGF: vascular endothelial growth factor derivatives, also inhibit VEGF expression and angiogenesis in vitro and in vivo [7, 8] . Rapamycin decreases vessel density in several solid tumors through inhibiting VEGF production and the response of vascular endothelial cells to VEGF [8, 9] . Sekiguchi et al. demonstrated that rapamycin blocks the hypoxia-induced angiogenic effects through inhibiting HIF-α [10] . It has also been reported that the inhibitory effect of rapalog CCI-779 on rhabdomyosarcoma was associated with the targeting of mTOR/HIF-1α/ VEGF signaling [11] . These evidences suggest that mTOR is a promising therapy target of tumor angiogenesis. Several chalcone compounds exhibit antiangiogenesis activity [12] . Cardamonin is a chalcone compound (l " Fig. 1 ) extracted from the seeds of Alpinia katsumadai Hayat. (Zingiberaceae). It inhibits the proliferation of many cancer cells, including colon cancer, non-small cell lung carcinoma, and prostate cancer cells [13] . Our previous studies revealed that the pharmacological activity of cardamonin was related to mTOR inhibition [14] [15] [16] . In this study, we investigated the inhibitory effect of cardamonin on angiogenesis in CoCl 2 -mimicked hypoxic ovarian cancer cells.
Results
!
To investigate the potential cytotoxicity of cardamonin, we examined the effect of cardamonin on the proliferation of SKOV3 cells. Treated with cardamonin (1, 3, 10, 30 µM) for 48 h, cell viability was inhibited in a concentration-dependent manner under both normoxia and CoCl 2 -mimicked hypoxia conditions (l " Fig. 2 ). VEGF is an effector for hypoxia that stimulates the formation of new vessels. Here we attempted to investigate the effect of cardamonin on the expression and secretion in SKOV3 cells. Under both conditions, the contents of protein expression and secretion from cells of VEGF were inhibited by cardamonin in dose-dependent manners (l " Fig. 3 A a, b , B). To determine if the reduced protein expression of VEGF results from transcriptional inhibition, the mRNA level of VEGF was measured. In accordance with the protein expression, the mRNA amount of VEGF was decreased by cardamonin in SKOV3 cells and in hypoxic SKOV3 cells (l " Fig. 3 C) .
The effect of cardamonin on HIF-α expression was determined to clarify its mechanism on VEGF. Hypoxia significantly induced the protein expression in CoCl 2 -treated SKOV3 cells. Treated with rapamycin and cardamonin, the protein content of HIF-1α and HIF-2α was decreased by cardamonin (l " Fig. 3 A a, c, d ). However, compared with the control, the mRNA level of HIF-1α and HIF-2α was invariable in the presence of either drug under both conditions (l " Fig. 3 
D, E).
Since we previously demonstrated that cardamonin specifically inhibits the activation of mTOR, it encouraged us to explore the effect of cardamonin on mTOR regulation in HIF-α and VEGF under mimicked hypoxia conditions. As expected, the phosphorylation of mTOR and S6K1 was inhibited by cardamonin and rapamycin, respectively. Similarly with VEGF, the inhibitory activity on mTOR activation of cardamonin is more significant at 30 µM than at 3 µM, and the effect of cardamonin (30 µM) was stronger in CoCl 2 -mimicked hypoxic cells than in normoxic cells (l " Fig. 4 ).
We further verified the antiangiogenic activity of cardamonin in a chicken embryo allantoic membrane model. Incubated in SKOV3 cells as a medium, a number of allantoic vessels radiating in a "spoked wheel" pattern were grown towards the sponges. When either rapamycin or cardamonin was present, the radiating vessels were drastically reduced (l " Fig. 5 A, B) .
Discussion
!
Hypoxia could activate tuberous sclerosis complex 1/2, which suppresses the phosphorylation of mTOR [17] . Also, hypoxia negatively regulates mTOR by disturbing the interaction of mTOR and its activator [18, 19] . Previous studies demonstrated that a high concentration of CoCl 2 (300-600 µM) inhibited the activation of mTOR [20, 21] ; however, this inhibitory activity of CoCl 2 depends on the severity or duration of hypoxia. In this study, 150 µM of CoCl 2 -mimicked hypoxia increased the expression of HIF-α and VEGF without activating mTOR. Except for mTOR, PHD2 could modulate the expression of HIF-α and VEGF under hypoxic conditions. Hypoxia abrogates the activity of PHD2 and encourages the transcription of HIF-1α and synthesis of VEGF as well as other proangiogenic molecules [22, 23] . Therefore, hypoxia could modulate the expression of VEGF and HIF-α without inhibiting the phosphorylation of mTOR. Treated with cardamonin and rapamycin, the phosphorylation of mTOR and its substrate S6K1 was inhibited in SKOV3 cells under hypoxic and normoxic conditions. In addition, the inhibitory activity of cardamonin on the mTOR signal pathway was more effective in CoCl 2 -mimicked hypoxic cells. We postulate that the sensitivity of cardamonin to mTOR is increased under CoCl 2-mimicked hypoxic conditions. Several investigators reported that rapamycin reduced the expression of VEGF in the mRNA and protein levels as well as the content of HIF-1α protein under hypoxic conditions. However, the level of HIF-1α mRNA was nearly unchanged in the presence of rapamycin in hypoxic cells [24, 25] . It needs to be illustrated whether mTOR inhibition regulates the translation and stability of HIF-α. Similar with these studies, the protein content of HIF-1α, HIF-2α, and VEGF was decreased by cardamonin, while the mRNA expression of HIF-1α and HIF-2α was not affected under both normoxic and CoCl 2 -mimicked hypoxic conditions. Interestingly, the protein expression of HIF-α seems to be sensitive to low doses of cardamonin. Compared with cardamonin at a concentration of 3 µM, the inhibitory activity of cardamonin at 30 µM was decreased on HIF-α protein expression. It has been reported that the hyperactivation of mTOR/S6K1 negatively regulates the IRS-1/PI3K/Akt signaling pathway. It prevents the activation of mTORC2 and its target Akt. Rapamycin inhibits the acti- The relative density ratios of proteins normalized to actin, compared with the normoxia control. B VEGF secretion in the media determined by ELISA (n = 5). C, D, E mRNA expressions of VEGF, HIF-1α, and HIF-2α determined by RT-PCR (n = 3). The relative expression ratios of mRNA were normalized to actin and compared with the normoxia control. Data are presented as the mean ± SD. * P < 0.05, ** p < 0.01 compared to the normoxia control; ## p < 0.01 compared to the CoCl 2 control. vation of mTORC1 and eliminates the negative feedback loop, leading to an mTORC2-dependent activation of Akt and the upregulation of HIF-α [26] [27] [28] . Our recent study found that cardamonin decreased the expression and phosphorylation of raptor (an essential component of mTORC1), indicating that cardamonin is a specific mTORC1 inhibitor. In addition, cardamonin eliminated the feedback of mTOR on the insulin signaling pathway through decreasing the negative Ser 636/639 phosphorylation of IRS-1 [14] . We postulate that the intensive inhibition of cardamonin at 30 µM on mTORC1 and S6K1 leads to an upregulation of IRS-1 and therefore to the coupling of insulin-like growth factor in the PI3K/Akt/mTOR pathway, which ultimately results in an increased expression of HIF-α. As indicated above, the inhibitory activity of cardamonin at 30 µM on the protein level of HIF-α was weaker than at 3 µM.
However, the inhibitory activity of cardamonin on the expression of VEGF is dose dependent. It has been proven that the production of VEGF is partially regulated by mTOR [29] . In addition to mTOR, NF-κB could also activate VEGF expression independently of HIF. NF-κB inhibition resulted in a decreased protein amount of VEGF and in a corresponding decrease of tumor angiogenesis in human prostate cancer cells [30, 31] . Some studies, and our unpublished data, proved that cardamonin decreased the amount of p65 NF-κB in the nucleus. Furthermore, cardamonin attenuated the transcriptional activity of p65 NF-κB through repressing the expression and phosphorylation of IκB kinase [32, 33] . Therefore, we hypothesized that the discordant inhibitory activity of cardamonin on HIF and VEGF expression was associated with the dual inhibition on the mTOR and NF-κB pathways. Except for the inhibition on the expression of proangiogenic molecules, cardamonin suppresses the proliferation of endothelial cells. Tian et al. demonstrated that cardamonin suppresses VEGF-induced angiogenesis in the mouse aortic ring assay as well as the proliferation and migration of human umbilical vein endothelial cells [33] . In accordance with these studies, the present results of the chicken embryo allantoic membrane model imply that cardamonin inhibits angiogenesis induced by media of cancer cells. These findings suggest that cardamonin inhibits the protein expression of HIF-α and VEGF in CoCl 2 -mimicked hypoxic conditions and this suppressive activity partially correlates with mTOR inhibition. Cardamonin might be considered and developed as a promising inhibitor for antiangiogenic therapy.
Materials and Methods
!
Reagents
Solutions and supplements for cell culture were purchased from Gibcol. Cardamonin (purity ≥ 98%), rapamycin (purity ≥ 95 %), CoCl 2 , and 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) were purchased from Sigma. Antibodies against mTOR, phospho-mTOR (Ser 2448), S6K1, phospho-S6K1 (Thr 389), HIF-1α, HIF-2α, and VEGF were purchased from Cell Signaling Technologies.
Cell culture
The human epithelial ovarian cancer cell line SKOV3 was obtained from the Boster Biological Engineering Co., Ltd., and cultured in McCoyʼs 5A medium supplemented with 10% FBS, penicillin (100 U · mL −1 ), and streptomycin (100 µg · mL −1 ). The cells were cultured with 150 µM of CoCl 2 to mimic hypoxia.
3-(4,5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide assay
Cells were cultured overnight in 96-well plates (8 × 10 3 cells per well). Cell viability was assessed after the addition of cardamonin or rapamycin at the indicated concentrations for 48 h in the presence of 5% FBS. The number of surviving cells was assessed by the determination of the A 490 nm of the dissolved formazan product after the addition of MTT (5 mg · mL −1 ) for 4 h. The inhibition rate was expressed as follows: (1 − A exp group /A control ) × 100.
Quantitative real-time PCR analyses
Total RNA was extracted with Trizol reagent. RNA concentrations were measured with a spectrophotometer at 260 nm. One µg of RNA was reverse transcribed into cDNA using a First Strand cDNA Synthesis Kit according to the manufacturerʼs protocol. Quantitative real-time PCR was performed using SYBR Green PCR kits with cDNA samples of different groups as templates. The nucleotide sequences of the primers were: 5′-GAT GTA ATG CTC CCC TCA C-3′ (sense) and 5′-GCT GGA ATA CTG TAA CTG TGC-3′ (antisense) for HIF-1α; 5′-GTC TCT CCA CCC CAT GTC TC-3′ (sense) and 5′-GGT TCT TCA TCC GTT TCC AC-3′ (antisense) for HIF-2α; 5′-CCT TGC CTT GCT GCT CTA CCT C-3′ (sense) and 5′-TTC TGC CCT CCT CCT TCT GC-3′ (antisense) for VEGF; and 5′-ACT GGA ACG GTG AAG GTG AC-3′ (sense) and 5′-AGA GAA GTG GGG TGG CTT TT-3′ (antisense) for β-actin. All real-time PCRs were performed in an Applied Biosystems 7500 real-time PCR system as follows: initial denaturation for 10 s at 95°C, and then by 40 cycles of 94°C for 30 s; 60°C for 30 s and 72°C for 30 s. The quantification of PCR products was calculated from a standard curve. Copy ratios of HIF-1α, HIF-2α, and VEGF to β-actin were reckoned in each group.
Vascular endothelial growth factor assay
Cells were treated with the indicated drugs for 24 h. The conditioned medium was collected and clarified by centrifugation at 2000 rpm for 10 min. The concentration of secreted VEGF was measured using the Quantikine ELISA kit from R&D Systems following the manufacturerʼs instructions. Results were normalized to cell count.
Western blot analysis
Cells were treated with the indicated drugs for 24 h. Cells were washed twice with ice-cold PBS and lysed in RIPA lysis buffer for 30 min at 4°C. Lysates were centrifuged at 15 000 × g at 4°C for 20 min, and protein concentrations of the supernatants were determined using BCA protein assay reagent. Equal amounts of proteins were separated by SDS-PAGE and transferred to polyvinylidene difluoride filters. Blocking was done in 5% BSA in 1× TBST for 1 h. Western blot analysis was done with various specific primary antibodies. Immunoblots were visualized with horseradish peroxidase-coupled goat anti-rabbit immunoglobulin by using the enhanced chemiluminescence and exposure to X-ray film to produce bands.
Preparation of the conditioned medium
The conditioned medium was prepared as previously described [34] . SKOV3 cells were harvested in the trypsin solution and washed with PBS twice. The cells were placed in 25 cm 2 culture flasks (5 × 10 6 cells per flask) in complete media for 2 days. Then, the media were changed with serum-free media and the cells were cultured for 48 h more. At the end of the incubation, the conditioned medium was collected, sequentially centrifuged at 12 000 × g for 10 min, filtered through 0.22 µm pore size filters, and stored at − 80°C.
Chicken embryo allantoic membrane assay
The chicken embryo allantoic membrane assay was carried out as previously described [35] . Chicken eggs (10 per group) were incubated at 37°C with constant humidity. On day 3, a square window was opened in the shell, and 2-3 mL of albumen were removed to allow for detachment of the developing chicken embryo allantoic membrane. Then the eggs were returned to the incubator. Cardamonin (3, 30, 300 µM) and rapamycin (10 µM) were dissolved in the conditioned medium. On day 7, 1 mm
